Gencurix Company Description

Gencurix Inc. provide diagnostic solutions in South Korea.

Its products include GenesWell BCT, a prognosis diagnostic test for breast cancer; GenesWell ddEGFR Mutation Test, a companion test for lung cancer; Droplex, a genetic test that detects DNA mutations; eDX, an early diagnosis for cancer with liquid biopsy; GenePro COVID-19 detection test; GenePro SARS-CoV-2 Test kit; GenoCTC (circulating tumor cell isolator); GenePro LAMP test solution for rapid, convenient and simple detection of various infectious diseases; and GenePro LAMP Cycler, a device for loop-mediated isothermal amplification.

The company was founded in 2011 and is headquartered in Seoul, South Korea.

Gencurix Inc.

Country	South Korea
Founded	2011
Industry	In Vitro and In Vivo Diagnostic Substances
Employees	69
CEO	Sung-Rai Cho

Contact Details

Address: Hanhwa Bizmetro Seoul, 152-733 South Korea
Phone	82 2 2621 7038
Website	gencurix.com

Stock Details

Ticker Symbol	229000
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2835

Key Executives

Name	Position
Sung-Rai Cho	Chief Executive Officer